Abstract: Examples described herein relate to a graphics processing system that includes one or more integrated graphics systems and one or more discrete graphics systems. In some examples, an operating system (OS) or other software supports switching between image display data being provided from either an integrated graphics system or a discrete graphics system by configuring a multiplexer at runtime to output image data to a display. In some examples, a multiplexer is not used and interface supported messages are used to transfer image data from an integrated graphics system to a discrete graphics system and the discrete graphics system generates and outputs image data to a display. In some examples, interface supported messages are used to transfer image data from a discrete graphics system to an integrated graphics system and the integrated graphics system uses an overlay process to generate a composite image for output to a display.

Abstract: A method and apparatus for organizing events. The method can include processing event information associated with an event, storing the event information, and transmitting participant information related to the event to computing devices associated with participating users. The apparatus can be used to communicate information regarding an event. If the apparatus is being used to organize an event, the apparatus can transmit event information associated with an event, and if the apparatus is being used to participate in an event, the apparatus can receive participant information related to the event.

Abstract: A method for identifying a bridge node in a network using a processor and memory unit in a specially programmed special purpose-purpose computer including the steps of, for each node in a plurality of nodes in the network: determining a global metric proportional to total traffic flow in the network and through the node; determining a local metric proportional to traffic flow between the node and each second node in the network connected to the node and traffic flow between each second node and each third node in the network connected to a second node; determining a second local metric proportional to the respective traffic flows between each node and each second node; and calculating a respective combination of the global metric and the first and second local metrics; and selecting, a bridge node from among the plurality of nodes based on the respective combinations.

Abstract: A method for identifying a bridge node in a network using a processor and memory unit in a specially programmed special purpose-purpose computer including the steps of, for each node in a plurality of nodes in the network: determining a global metric proportional to total traffic flow in the network and through the node; determining a local metric proportional to traffic flow between the node and each second node in the network connected to the node and traffic flow between each second node and each third node in the network connected to a second node; determining a second local metric proportional to the respective traffic flows between each node and each second node; and calculating a respective combination of the global metric and the first and second local metrics; and selecting, a bridge node from among the plurality of nodes based on the respective combinations.

Abstract: Automatic text generation is marked in a text document to allow later re-invocation of automatic text generation to revise the expanded text and to ensure integrity in capture of machine interpretable data generated during automatic text generation.

Abstract: The present invention provides a blood based method for estimation of drug metabolizing enzyme RNAs in liver. The method comprises the steps of obtaining a blood sample from an individual, isolating one or more types of cells from the sample, preparing total RNA or mRNA from the cells and subjecting the RNA to DNA arrays comprising probes for desired genes to determine the levels of the mRNAs. These levels are then used to estimate corresponding mRNA levels in liver.

Abstract: A digital subscriber line (DSL) multiplexer is used in conjunction with a DSL modem to provide a reliable high speed connection for an end-user. The scaleable DSL multiplexer supports multiple DSL modems to a number of subscriber desiring increased bandwidth. The connection is reliably maintained by the multiplexer which utilizes a proprietary protocol to exchange management information to monitor the connection.

Abstract: The present invention relates to a method of screening for drug binding to serum proteins by: preparing at least two solutions each including a concentration of a serum protein and a concentration of a candidate drug, wherein the concentration of the candidate drug is different for each of the at least two solutions; exposing each of the at least two solutions to a light source; measuring fluorescent emission by the serum protein or a serum protein-candidate drug complex for each of the at least two solutions upon said exposing; and determining whether a change in fluorescence emission is measured for an increased concentration of the candidate drug, wherein the change in fluorescence emission indicates binding of the candidate drug to the serum protein. A kit useful for performing a fluorimetric screening of drug binding to serum proteins is also disclosed.

Abstract: A modem using digital subscriber line (DSL) provides high speed access over a copper plant. The DSL modem exchanges management information to a terminating multiplexer using a proprietary protocol, thus enabling reliable, fast access to networking resources.

Abstract: The present invention relates to a method of screening for drug binding to serum proteins by: preparing at least two solutions each including a concentration of a serum protein and a concentration of a candidate drug, wherein the concentration of the candidate drug is different for each of the at least two solutions; exposing each of the at least two solutions to a light source; measuring fluorescent emission by the serum protein or a serum protein-candidate drug complex for each of the at least two solutions upon said exposing; and determining whether a change in fluorescence emission is measured for an increased concentration of the candidate drug, wherein the change in fluorescence emission indicates binding of the candidate drug to the serum protein. A kit useful for performing a fluorimetric screening of drug binding to serum proteins is also disclosed.